StimCell Enegetics Inc
OTC:STME
StimCell Enegetics Inc
OTC:STME
Price:
0.3001
USD
4.93%
Market Cap:
$6.3m
Relative Value
There is not enough data to reliably calculate the relative value of STME.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
STME
Relative Value
Base Case
Not Available
Multiples Across Competitors
STME Competitors Multiples
StimCell Enegetics Inc Competitors
StimCell Enegetics Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CA |
|
StimCell Enegetics Inc
OTC:STME
|
6.3m USD | 0 | -6.7 | -8 | -8 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
192.8B USD | 4.3 | 29.4 | 16.9 | 23.2 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
173.4B USD | 17.1 | 60.4 | 45.8 | 56.3 | |
| US |
|
Stryker Corp
NYSE:SYK
|
138.7B USD | 5.5 | 42.3 | 21.5 | 26 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
116.1B USD | 3.3 | 25 | 13.7 | 20 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
104.5B USD | 5.2 | 35.8 | 21 | 28.2 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
45.1B EUR | 1.9 | 21.2 | 11.8 | 16.6 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
49.8B USD | 8.2 | 46.5 | 25.6 | 28.1 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
48.3B USD | 11.1 | 45.1 | 32 | 35.4 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
47.2B USD | 2.1 | 26.6 | 10.4 | 17.5 | |
| US |
|
Resmed Inc
NYSE:RMD
|
36.3B USD | 6.7 | 24.2 | 17.1 | 19 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
